CeNeRx BioPharma Raises $15 Million

CeNeRx BioPharma Inc., a Cary, N.C.-based developer of CNS drugs, has raised $15 million in Series B funding. Return backers include Aisling Capital, L Capital Partners and Pappas Ventures.

North AmericaUSBriefs